Use of Botulinum Toxin Type a in the Treatment of Spasticity

Abstract

Spasticity is a component of the upper motor neuron syndrome and occurs after maladaptive improvement. Velocity-dependent increase in muscle tonus causes restricted movement, muscle shortness, pain, joint malpositions and contractures. When spasticity is harmful, it has to be treated. The treatment of spasticity requires a multidisciplinary approach. Botulinum toxin type A is effective when used with other treatment modalities, especially with physiotherapy. (Archives of Neuropsychiatry 2010; 47 Supplement: 40-3)